<PAGE> 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K/A
AMENDMENT TO REPORT FILED
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
AMENDMENT NO. 1
Date of Report (Date of earliest event reported): November 3, 2000
BIOMUNE SYSTEMS, INC.
(Exact name of registrant as specified in its charter)
Nevada 0-11472 870380088
------------------------------ --------------- --------------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
64 East Winchester Drive, Suite 303, Salt Lake City, Utah 84107
---------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (801) 466-3441
2401 South Foothill Drive, Salt Lake City, Utah 84109-1405
----------------------------------------------------------
(Former name or former address, if changed since last report.)
<PAGE> 2
The undersigned registrant hereby amends the following items, financial
statements, exhibits or other portions of its Report on Form 8-K dated November
3, 2000 as set forth in the pages attached hereto.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
The exhibits are amended by filing the following exhibit:
(a) Not Applicable.
(b) Not Applicable.
(c) Exhibits:
Exhibit No. Exhibit Description
16 Letter regarding change in certifying accountant
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
BIOMUNE SYSTEMS, INC.
By: /s/ Larry P. Koskan
------------------------------------------
Its: President and Chief Executive Officer
Date: December 14, 2000
<PAGE> 3
EXHIBIT INDEX
Exhibit No. Exhibit Description
16 Letter regarding change in certifying accountant.
